MYSIMBA
Prolonged-release tablet, 90mg/8mg
RxActive license
Active substance (INN)
bupropionnaltrexone
Pharmaceutical form
Pharmaceutical formProlonged-release tablet
Strength90mg/8mg
PackagingUkupno 112 tableta sa produženim oslobađanjem u blisteru (4x28) u kartonskoj kutiji
ManufacturerMias Pharma Limited, Ireland
Therapeutic groupAlimentary tract and metabolism (A08AA62)
Marketing authorization holderPHARMASWISS - MONTENEGRO, PHARMASWISS DOO BEOGRAD, DIO STRANOG DRUŠTVA U PODGORICI
Authorization dateJanuary 14, 2026
Source: CInMED register